Building on the award-winning Allia platform for image guided therapies, GE HealthCare's new Allia IGS Pulse was designed to improve workflow for the diagnosis and treatment of cardiovascular diseases in interventional cardiology. (Photo: Business Wire) 
October 16, 2023
GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence
October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest…
Read More
Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S. installation of a Trinias SCORE Opera C12 (ceiling mounted cutting edge angiography system) at Beaufort Memorial Hospital (Beaufort, SC).
October 16, 2023
Shimadzu Medical Systems USA Installs First Trinias Score Opera Cardiac Catheterization Lab in the US
October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S.…
Read More
SpotLight Duo is the second generation Arineta CT that it will sell and service directly
October 13, 2023
Arineta announces SpotLight Duo
October 13, 2023 — Arineta Cardiac Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and…
Read More
InfoBionic announces FDA 510(k) clearance for its MoMe ARC solution that encompasses our next generation remote ECG monitoring device and initial Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias
October 13, 2023
InfoBionic Receives FDA 510(k) Clearance for its Next Generation MoMe ARC Solution
October 13, 2023 — InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug…
Read More
The software updates introduce fast-track analysis and a user-friendly layout for quicker review of ECG findings, enhancing efficiency for medical professionals
October 13, 2023
Cardiomatics Obtains the World’s 1st MDR Certification for AI-based ECG Interpretation and Implements new Functionalities
October 13, 2023 — The newly MDR-certified Cardiomatics solution is accurate, fast and easy-to-use AI-based standalone…
Read More
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
October 12, 2023
Philips and World Stroke Organization Partner to Improve Access to High-quality Stroke Care
October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the…
Read More
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
October 12, 2023
UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound
October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which…
Read More
Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays
October 12, 2023
BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later
October 11, 2023
Unvaccinated Covid-19 Survivors Face Higher Risk of Heart Complications, Singapore Study Finds
October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications…
Read More
Combination of Tenaya’s HDAC6 inhibitors with Empagliflozin Shows Additive Benefits in Preclinical HFpEF Model and Highlights Differentiated Mechanism of Action
October 11, 2023
Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting
October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover,…
Read More
Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes
October 11, 2023
GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes
October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio,…
Read More
October 10, 2023
American Heart Association Presidential Advisory defines cardiovascular-kidney-metabolic (CKM) syndrome for first time
October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections…
Read More
Christine Book
October 10, 2023
“One on One” with Christine Seidman, MD, FACC, on Hypertrophic Cardiomyopathy
October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy,…
Read More
REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months
October 10, 2023
Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy
October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6-…
Read More
The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average
October 10, 2023
Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study
October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the…
Read More
Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk
October 10, 2023
Elixir Medical To Present Randomized Clinical Dataset Featuring World’s First Triple Drug-Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus at TCT 2023
October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present…
Read More
October 10, 2023
Cardiovascular Research Foundation Announces TCT 2023 Award Winners
October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O.…
Read More
World Stroke Day October 29, 2023
October 10, 2023
Philips in Partnership with the World Stroke Organization: Putting Stroke on the Global Agenda
The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total,…
Read More
The program is recommended by the Centers for Medicare and Medicaid services for patients who undergo heart valve repair or replacement
October 09, 2023
TAVR: Less Than One-third of Patients Enter Cardiac Rehab After Heart Procedure
October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not…
Read More
Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a mouse model of arrhythmogenic cardiomyopathy (ACM)
October 09, 2023
Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy
October 9, 2023 — Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now